Angel discovery
They’re founders, operators, executives, and experts who quietly write checks—but rarely list “angel investor” anywhere. Hidden Angels helps you find them.
Last signal: 4 days ago
$25K check into a dev-tools startup
“...quietly wrote one of the earliest checks...”
Second appearance in a seed round this year
VP Engineering, fintech scale-up
Active in a founder Slack thread 6 days ago
Co-invested alongside a $50K lead angel
VCs publish their investment activity.
Most angels do not.
Hidden Angels pieces together the evidence.
Hidden Angels + Raise Room
Public signals, research, evidence, activity, and likely relevance.
This is what members are actually asking each other right now:
Anyone pitched Angel #481? Deciding whether to prioritize the intro.
Pitched him in March. Fast replies, but he'll ask hard questions about margins before check size.
Sharing my deck ahead of Thursday's call. Would love a gut check on slide 4.
Founders share what databases can’t.
Databases tell you who. Founders tell you what happened.
The research process
Every profile starts as scattered evidence — a podcast mention, a disclosed check, a line in someone’s bio. We track it, verify it, and turn it into research you can act on.
Raw signals
“...quietly backs a few founders a year, nothing public.”
Seed round, developer tools startup
Congratulated a founder on closing their raise
“Ex-Stripe. Advisor. Occasional investor.”
Verified profile
Signal strength: High
Angel intelligence
Western Europe
$10K–$25K
Climate & industrial transition
Why this may matter. Recent portfolio activity and public commentary both point toward an active, thesis-driven angel currently writing early checks in climate-adjacent sectors.
Updated 6 days ago
United States
$15K–$40K
Fintech & financial infrastructure
Why this may matter. A fintech operator background combined with a recent disclosed check suggests active, hands-on angel investing rather than dormant capital.
Updated 3 days ago
Europe & United States
$20K–$50K
Developer tools & infrastructure
Why this may matter. Cross-border thesis alignment and a recent disclosure suggest relevance for founders building developer-facing infrastructure right now.
Updated 11 days ago
United Kingdom
$10K–$30K
Healthtech & clinical operations
Why this may matter. Operator history plus a recent first-time-founder check suggests both domain relevance and an active appetite for early-stage healthtech risk.
Updated 8 days ago
Membership
One membership, two integrated parts: the research that finds the angels, and the founder network that tells you what they’re actually like to raise from.
Public signals, research, evidence, and likely relevance — new profiles added regularly.
A private founder network to compare notes, review decks, and get real answers before you take the meeting.
or $300 billed annually